1 d the green fluorescent protein (GFP) to the human papillomavirus type 11 E1 protein either in a plas

2 report that, in the assays of our study, the human papillomavirus type 11 (HPV-11) E1 protein functio

3 uorescent protein (GFP) with the full-length human papillomavirus type 11 (HPV-11) E2 protein and sho

4 ve used chimeric bovine papillomavirus (BPV)/human papillomavirus type 11 (HPV-11) E2 proteins.

5                   Peptide antagonists of the human papillomavirus type 11 (HPV-11) E2-DNA association

6                            Neutralization of human papillomavirus type 11 (HPV-11) has been demonstra

7                                          The human papillomavirus type 11 (HPV-11) L1 major capsid pr

8  we investigate the interactions between the human papillomavirus type 11 (HPV-11) origin recognition

9               The L1 major capsid protein of human papillomavirus type 11 (HPV-11) was expressed in E

10  that the viral origin binding protein E2 of human papillomavirus types 11 (HPV-11), 16, and 18 coloc

11 Neutralizing monoclonal antibodies (MAbs) to human papillomavirus type 11 (HPV11) have been described

12 onoclonal antibodies (MAbs) which neutralize human papillomavirus type 11 (HPV11) in the athymic mous

13 ecombinant murine polyomavirus (mPy) VP1 and human papillomavirus type 11 (HPV11) L1 capsomeres bound

14     Analysis of the interactions of low-risk human papillomavirus type 11 (HPV11) L2 with karyopherin

15 ing protein (C/EBP) transcription factors on human papillomavirus type 11 (HPV11).

16                          Infectious CRPV and human papillomavirus type 11 L1 VLPs were used as positi